- Global Healthcare Companies+
- 3M Healthcare
- AbbVie
- Actelion
- Air Liquide
- Alcon
- Alexion
- Alnylam
- Amgen
- Astellas
- AstraZeneca
- Baxter International / Baxalta
- Bayer Pharmaceuticals
- Biogaran
- bioMerieux
- BMS
- Boehringer Ingelheim
- Boots Healthcare
- Danone
- Edwards Lifesciences
- Expanscience
- Ferring
- Galderma
- Genzyme
- Germitec
- GlaxoSmithKline
- GSK biologicals
- Guerbet
- IBA Molecular
- Implanet
- Intercept
- Iprad
- Ipsen
- Janssen-Cilag
- Johnson & Johnson
- L'Oréal
- Leo
- LFB Biomedicaments
- Locemia
- Lundbeck
- Medac
- Medtronic
- Merck
- Merck & Co
- Merck Médication Familiale
- Merial
- Neovacs
- Nestle Health Sciences
- Neurim Pharmaceuticals
- Novartis
- Orion
- Pierre Fabre
- Roche
- Sanofi
- Sanofi Pasteur
- Servier
- Shire
- St Jude Medical
- Stallergenes
- Takeda
- Teoxane
- Teva
- UCB
- Upsa
- Urgo
- Veeva
- Vetoquinol
- Zogenix
- Start-Ups & Research Organizations+
- AFM Telethon
- Canceropole Grand Sud Ouest
- Canceropole Ile-de-France
- CLL Pharma
- CNRS
- Cypress
- Genome Express
- Inserm
- Institut Pasteur
- LBMA
- Medicen
- MedinCell
- Pharnext
- Septeos
- Government & Professional Organizations+
- Agipharm
- AMIPS
- CeNGEPS
- Economie & Santé
- EFPIA
- Gemme
- Handiem
- LEEM
- LIR
- Roszdravnadzor
- Société Française d’Ophtalmologie
- Pharmaceutical Service Providers+
- Amatsi
- Bertin Technologies
- Carso
- Ethypharm
- GERS
- Quintiles
- Private Equity+
- 3i
- Advent Venture Partners
- Agence des Participations de l’Etat
- Apax Partners
- Azulis Capital
- Chequers Capital
- Cognetas
- Edmond de Rothschild Capital Partners
- Edmond de Rothschild Investment Partners
- G Square Capital
- ING Parcom Private Equity
- Investcorp
- LBO France
- Lyxor Asset Management
- Oddo & Cie
- Perfectis Private Equity
- Pragma Capital
- Wendel
- YAM Invest